A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF TWO LENALIDOMIDE DOSE REGIMENS IN SUBJECTS WITH RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004469-32

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of two dose regimens of lenalidomide in subjects with relapsed or refractory B-cell chronic lymphocytic leukemia (CLL)


Critère d'inclusion

  • For the treatment of relapsed or refractory B-CLL